A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children
Completed
GlaxoSmithKline
Phase 2
2017-11-07
The purpose of this study is to see if treatment with a medication called Nucala®
(mepolizumab), given along with standard asthma care, makes children less likely to have
asthma attacks.
A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children
Completed
Inner-City Asthma Consortium
Phase 2
2017-11-07
The purpose of this study is to see if treatment with a medication called Nucala®
(mepolizumab), given along with standard asthma care, makes children less likely to have
asthma attacks.
A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children
Completed
Rho Federal Systems Division, Inc.
Phase 2
2017-11-07
The purpose of this study is to see if treatment with a medication called Nucala®
(mepolizumab), given along with standard asthma care, makes children less likely to have
asthma attacks.
A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children
Completed
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2
2017-11-07
The purpose of this study is to see if treatment with a medication called Nucala®
(mepolizumab), given along with standard asthma care, makes children less likely to have
asthma attacks.
Mepolizumab for the Treatment of Chronic Spontaneous Urticaria
Recruiting
GlaxoSmithKline
Early Phase 1
2019-07-30
This is an exploratory study designed to generate preliminary data in evaluating the efficacy
of Nucala in the treatment of chronic spontaneous urticaria.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
